Discovery Technologies, Roche Research Center, Nutley, NJ 07110, USA.
Curr Pharm Des. 2012;18(30):4679-84. doi: 10.2174/138161212802651634.
This systematic review describes successful examples of small-molecule inhibitors of protein-protein interactions, and compares their binding strategies to those employed by the natural protein partners. It extends and updates an earlier survey of this type (Fry DC, Curr Prot Pep Sci 2008; 9: 240-7). From analysis of these systems, common themes and lessons are presented that may assist future drug discovery efforts involving targets in this class. One encouraging finding is that a wide scope appears to be allowed at these sites in terms of binding strategies and chemotypes, which suggests that the outlook for finding small-molecule protein-protein inhibitors is favorable.
这篇系统综述描述了小分子蛋白-蛋白相互作用抑制剂的成功范例,并将它们的结合策略与天然蛋白配体的策略进行了比较。它扩展和更新了早期对此类抑制剂的调查(Fry DC,Curr Prot Pep Sci 2008;9:240-7)。通过对这些系统的分析,提出了一些常见的主题和经验教训,这可能有助于未来涉及此类靶点的药物发现工作。一个令人鼓舞的发现是,这些结合部位似乎允许采用广泛的结合策略和化学型,这表明寻找小分子蛋白-蛋白抑制剂的前景是乐观的。